Dr. Michael C. Treisman, MD

Dr. Treisman practices at Mercy Hospital St. Louis in Saint Louis, Missouri, part of Mercy.

Dr. Treisman's NPI, 1184685455, was assigned on March 28, 2006. Dr. Treisman holds Missouri license 105350.

Dr. Treisman's primary practice is Mercy Hospital St. Louis, at 615 New Ballas Road, Saint Louis, MO 63141 in St. Louis County. The practice phone is (314) 251-6000.

Dr. Treisman's primary practice is Mercy Hospital St. Louis in Saint Louis, Missouri, part of Mercy. Dr. Treisman is also affiliated with Missouri Baptist Medical Center. The medical group on file is Mercy Clinic East Communities. Dmand AI also links Dr. Treisman to 4 more hospitals, 1 group practice or clinic, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Treisman practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Treisman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Treisman is licensed in Missouri.

CMS data shows 990 Medicare services from Dr. Treisman across 5 procedure codes in 2024, for 380 Medicare patients. Medicare paid $81,628 for them. Every service was in an office.

CMS counts 380 Medicare patients who saw Dr. Treisman in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Treisman's median patient age at 71, with 57% women.

In 2024, Dr. Treisman wrote 15,087 Medicare Part D claims for 1,279 patients. 86% of them were for generic drugs. CMS names the drug for 14,188 of them, across 194 drugs with 11 or more claims each, at $1,182,234 in total drug cost. In 2023, CMS named 13,181 claims across 179 drugs.

Dr. Treisman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Treisman as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 673 general payments to Dr. Treisman from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $1,157. It also lists 1 research payment totaling $6,600 in 2024.